Toer Stevens

565 total citations
15 papers, 238 citations indexed

About

Toer Stevens is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Toer Stevens has authored 15 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Toer Stevens's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Anorectal Disease Treatments and Outcomes (4 papers). Toer Stevens is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Anorectal Disease Treatments and Outcomes (4 papers). Toer Stevens collaborates with scholars based in Netherlands, United States and Belgium. Toer Stevens's co-authors include Geert D’Haens, K Gecse, Christianne J. Buskens, Willem A. Bemelman, Ailsa Hart, Cyriel Y. Ponsioen, Judith E. Bosmans, Michael J. Meehan, Dilip V. Jeste and Johanna M. van Dongen and has published in prestigious journals such as Gastroenterology, Gut and Molecular Psychiatry.

In The Last Decade

Toer Stevens

13 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toer Stevens Netherlands	7	153	116	82	39	27	15	238
M. Anthony Sofia United States	9	145 0.9×	119 1.0×	53 0.6×	92 2.4×	35 1.3×	19	322
J. Florholmen Norway	11	57 0.4×	80 0.7×	97 1.2×	26 0.7×	48 1.8×	16	259
Jorunn Bratlie Norway	8	41 0.3×	166 1.4×	162 2.0×	27 0.7×	18 0.7×	10	408
Éloi Gagnon Canada	10	58 0.4×	77 0.7×	52 0.6×	75 1.9×	9 0.3×	26	235
N. To United Kingdom	5	140 0.9×	124 1.1×	92 1.1×	21 0.5×	22 0.8×	6	224
Bengt Lavö Sweden	8	54 0.4×	113 1.0×	158 1.9×	21 0.5×	40 1.5×	10	376
Hanne Callewaert Belgium	6	152 1.0×	36 0.3×	144 1.8×	58 1.5×	94 3.5×	6	379
Aneta Aleksandra Nielsen Denmark	8	62 0.4×	37 0.3×	33 0.4×	56 1.4×	17 0.6×	12	199
Abdul Rishi United States	8	20 0.1×	75 0.6×	79 1.0×	44 1.1×	19 0.7×	14	221
Nancy Langhans United States	6	97 0.6×	130 1.1×	197 2.4×	62 1.6×	19 0.7×	8	358

Countries citing papers authored by Toer Stevens

Since Specialization

Citations

This map shows the geographic impact of Toer Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toer Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toer Stevens more than expected).

Fields of papers citing papers by Toer Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toer Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toer Stevens. The network helps show where Toer Stevens may publish in the future.

Co-authorship network of co-authors of Toer Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Toer Stevens. A scholar is included among the top collaborators of Toer Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toer Stevens. Toer Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gonzalez, Carlos G., Toer Stevens, Bram Verstockt, et al.. (2024). Crohn’s Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab. Inflammatory Bowel Diseases. 30(9). 1536–1545.

Stevens, Toer, F de Voogd, Manon E. Wildenberg, et al.. (2024). Clinical relevance of calprotectin in patients with perianal fistulas in Crohn's disease and cryptoglandular fistulas. United European Gastroenterology Journal. 13(3). 295–304. 4 indexed citations

Stevens, Toer, et al.. (2023). P166 Calprotectin in patients with perianal fistula: the CANALS study. Journal of Crohn s and Colitis. 17(Supplement_1). i324–i325. 2 indexed citations

Campeau, Anaamika, Robert H. Mills, Toer Stevens, et al.. (2021). Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia. Molecular Psychiatry. 27(2). 1217–1225. 54 indexed citations

Stevens, Toer, Geert D’Haens, Christianne J. Buskens, et al.. (2020). OP03 Reduced need for surgery and medical therapy after early ileocaecal resection for Crohn’s disease: Long-term follow-up of the LIR!C trial. Journal of Crohn s and Colitis. 14(Supplement_1). S003–S004. 4 indexed citations

Stevens, Toer, K Gecse, Jerrold R. Turner, et al.. (2020). Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 19(11). 2333–2342. 24 indexed citations

Stevens, Toer, Geert D’Haens, Christianne J. Buskens, et al.. (2020). 284 EARLY LAPAROSCOPIC ILEOCECAL RESECTION DECREASES NEED FOR MEDICAL TREATMENT AND SURGERY IN INFLAMMATORY ILEOCECAL CROHN'S DISEASE: LONG-TERM FOLLOW UP OF THE LIR!C TRIAL. Gastroenterology. 158(6). S–55. 1 indexed citations

Novak, Gregor, Toer Stevens, Peter Bossuyt, et al.. (2019). Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease. Alimentary Pharmacology & Therapeutics. 49(11). 1401–1409. 17 indexed citations

Groof, E. Joline de, Toer Stevens, Emma J. Eshuis, et al.. (2019). Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial. Gut. 68(10). 1774–1780. 60 indexed citations

10.

Stevens, Toer, K Gecse, Karen Barrett, et al.. (2019). P161 Faecal calprotectin identifies microscopic inflammation in ulcerative colitis patients with complete endoscopic healing: a post-hoc analysis of the MOMENTUM trial. Journal of Crohn s and Colitis. 13(Supplement_1). S169–S169.

11.

Stevens, Toer, Geert D’Haens, Marjolijn Duijvestein, et al.. (2019). Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas. United European Gastroenterology Journal. 7(4). 496–506. 19 indexed citations

12.

Stevens, Toer, et al.. (2018). Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy. Alimentary Pharmacology & Therapeutics. 48(11-12). 1213–1231. 33 indexed citations

13.

Stevens, Toer, Geert D’Haens, Christianne J. Buskens, Willem A. Bemelman, & K Gecse. (2018). P150 Low diagnostic accuracy of faecal calprotectin to predict mucosal inflammation in Crohn’s disease patients with active perianal fistulas. Journal of Crohn s and Colitis. 12(supplement_1). S171–S171. 2 indexed citations

14.

Stevens, Toer, et al.. (2017). Risk of malignancy in 22q11.2 deletion syndrome. Clinical Case Reports. 5(4). 486–490. 17 indexed citations

15.

Stevens, Toer, et al.. (2005). ENZYME CONTENT IN SECRETIN-STIMULATED DUODENAL ASPIRATES IS PARADOXICALLY ELEVATED IN PATIENTS WITH CHRONIC PANCREATITIS. Pancreas. 31(4). 470–470. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact